Froelich syndrome
diseaseOn this page
Also known as Adiposodysgenesisadiposogenital dystrophyBabinski-Froelich syndromedystrophia AdiposogenitalisFroehlich's syndromeFroelich's adiposityFroelich's syndromeFrohlich syndromeFrohlich's syndromeFrolich's syndromeFröhlich syndromehypothalamic infantilism-obesityLaunois-Cleret syndromesexual infantilism
Summary
Froelich syndrome (MONDO:0003962) is a disease. A subtype of hypothalamic disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | Froelich syndrome |
| Mondo ID | MONDO:0003962 |
| DOID | DOID:6676 |
| NCIT | C34625 |
| SNOMED CT | 62999006 |
| UMLS | C0016724 |
| MedGen | 4795 |
| Is cancer (heuristic) | no |
Also known as: Adiposodysgenesis · adiposogenital dystrophy · Babinski-Froelich syndrome · dystrophia Adiposogenitalis · Froehlich’s syndrome · Froelich’s adiposity · Froelich’s syndrome · Frohlich syndrome · Frohlich’s syndrome · Frolich’s syndrome · Fröhlich syndrome · hypothalamic infantilism-obesity · Launois-Cleret syndrome · sexual infantilism
Disease family
Classification path: disease › human disease › disease by body system or component › nervous system disorder › central nervous system disorder › brain disorder › thalamic disorder › hypothalamic disorder › Froelich syndrome
Related subtypes (2): hypothalamic neoplasm, hypothalamic dysfunction
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.